Overview

Study to Evaluate MEDI-534 in Healthy Adults

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to describe the safety and tolerability of a single dose of MEDI-534 when administered to healthy adult volunteers.

Details

Lead Sponsor:

MedImmune LLC